Azitra Inc surged 80% after announcing a $31.4 million private placement to advance protein and peptide research. The stock crossed its 100-day moving average for the first time in over eight months. This rally follows a recent NYSE listing warning, as institutional investors back the biopharmaceutical firm's expansion into skincare solutions.